{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Blood+Vessel+Disease&page=3", "query": { "condition": "Blood Vessel Disease", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 13645, "total_pages": 1365, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Blood+Vessel+Disease&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Blood+Vessel+Disease&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-05T22:37:21.854Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07628829", "title": "Neonatal Neurological Observation With Video AI", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Neonatal Encephalopathy", "Hypoxic-Ischemic Encephalopathy", "Sedation", "Sleep" ], "interventions": [ { "name": "Continuous bedside video monitoring with AI anatomic landmark tracking for neurologic monitoring", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Artemis AI Labs", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 200, "start_date": "2026-07-13", "completion_date": "2029-07-12", "has_results": false, "last_update_posted_date": "2026-07-15", "last_synced_at": "2026-10-05T22:37:21.854Z", "location_count": 2, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07628829" }, { "nct_id": "NCT05259839", "title": "A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Relapsed/Refractory Multiple Myeloma" ], "interventions": [ { "name": "Etentamig", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Pomalidomide", "type": "DRUG" }, { "name": "Daratumumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 283, "start_date": "2022-10-20", "completion_date": "2033-09", "has_results": false, "last_update_posted_date": "2026-08-14", "last_synced_at": "2026-10-05T22:37:21.854Z", "location_count": 15, "location_summary": "Little Rock, Arkansas • Miami, Florida • Tampa, Florida + 11 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Miami", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05259839" }, { "nct_id": "NCT05756257", "title": "Blood Pressure Variability and Ischemic Stroke Outcome", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Acute Ischemic Stroke", "Blood Pressure Variability" ], "interventions": [], "intervention_types": [], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2024-07-15", "completion_date": "2027-07-15", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-05T22:37:21.854Z", "location_count": 3, "location_summary": "New Haven, Connecticut • Chicago, Illinois • Boston, Massachusetts", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05756257" }, { "nct_id": "NCT00208767", "title": "Effect of Valsartan on Carotid Artery Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Carotid Artery Diseases", "Atherosclerosis" ], "interventions": [ { "name": "Valsartan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "21 Years to 80 Years" }, "enrollment_count": 120, "start_date": "2005-02", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2015-12-08", "last_synced_at": "2026-10-05T22:37:21.854Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00208767" }, { "nct_id": "NCT05254067", "title": "Enterprise 2 Vascular Reconstruction Device", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Aneurysm" ], "interventions": [ { "name": "Codman Enterprise 2 Vascular Reconstruction Device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Methodist Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2017-02-28", "completion_date": "2026-01-05", "has_results": false, "last_update_posted_date": "2026-05-18", "last_synced_at": "2026-10-05T22:37:21.854Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05254067" }, { "nct_id": "NCT00178594", "title": "Evaluation of Hemostasis in Bleeding and Thrombotic Disorders", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Blood Coagulation Disorders, Inherited", "Thrombotic Disorder" ], "interventions": [], "intervention_types": [], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "98 Years", "sex": "ALL", "summary": "1 Day to 98 Years" }, "enrollment_count": 1000, "start_date": "2002-10", "completion_date": "2028-01", "has_results": false, "last_update_posted_date": "2025-01-09", "last_synced_at": "2026-10-05T22:37:21.854Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00178594" }, { "nct_id": "NCT00153166", "title": "ARREST PAD (Peripheral Arterial Disease)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Arterial Occlusive Disease", "Intermittent Claudication", "Insulin Resistance" ], "interventions": [ { "name": "atorvastatin and pioglitazone", "type": "DRUG" }, { "name": "atorvastatin/placebo", "type": "DRUG" }, { "name": "pioglitazone/placebo", "type": "DRUG" }, { "name": "placebo/placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 76, "start_date": "2004-01", "completion_date": "2011-12", "has_results": true, "last_update_posted_date": "2014-09-30", "last_synced_at": "2026-10-05T22:37:21.854Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00153166" }, { "nct_id": "NCT02333695", "title": "Medical Device for Magnetic Therapy for Spinal Cord Injuries (SCI)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spinal Cord Injury", "Stroke" ], "interventions": [ { "name": "Spinal Magnetic Stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "American Society Of Thermalism And Climatology Inc", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 50, "start_date": "2015-01", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2015-01-07", "last_synced_at": "2026-10-05T22:37:21.854Z", "location_count": 1, "location_summary": "Newark, New Jersey", "locations": [ { "city": "Newark", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02333695" }, { "nct_id": "NCT02082977", "title": "A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cancer", "Neoplasms" ], "interventions": [ { "name": "GSK2816126", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 41, "start_date": "2014-04-24", "completion_date": "2017-06-20", "has_results": true, "last_update_posted_date": "2020-02-25", "last_synced_at": "2026-10-05T22:37:21.854Z", "location_count": 2, "location_summary": "Chicago, Illinois • New York, New York", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02082977" }, { "nct_id": "NCT00963781", "title": "Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Coronary Artery Disease", "Coronary Thrombosis" ], "interventions": [ { "name": "Medtronic Endeavor Stent", "type": "DEVICE" }, { "name": "Reduced duration (6 months) DAPT", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Scripps Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 219, "start_date": "2009-08", "completion_date": "2013-08", "has_results": false, "last_update_posted_date": "2020-10-20", "last_synced_at": "2026-10-05T22:37:21.854Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00963781" } ] }